American Century Companies
PYXS icon

American Century Companies’s Pyxis Oncology PYXS Stock Holding History

American Century Companies’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,936
Closed -$36.7K – 2903
2025
Q4 		$36.7K Buy
+31,936
New +$113K ﹤0.01% 2801
2025
Q2 		– Sell
-26,353
Closed -$25.8K – 2923
2025
Q1 		$25.8K Sell
26,353
-273,584
-91% -$365K ﹤0.01% 2879
2024
Q4 		$468K Buy
299,937
+140,498
+88% +$405K ﹤0.01% 2537
2024
Q3 		$585K Buy
159,439
+101,187
+174% +$354K ﹤0.01% 2422
2024
Q2 		$193K Buy
58,252
+20,901
+56% +$87.9K ﹤0.01% 2732
2024
Q1 		$159K Buy
37,351
+23,580
+171% +$99.2K ﹤0.01% 2802
2023
Q4 		$24.8K Hold
13,771
– – ﹤0.01% 2869
2023
Q3 		$27.4K Buy
+13,771
New +$31.9K ﹤0.01% 2830

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies's PYXS Position: Q1 2026 in Review

American Century Companies sold out of Pyxis Oncology (PYXS) in Q1 2026, closing a stake of 31,936 shares — an estimated $36.7K sold.

American Century Companies first reported a position in PYXS in Q3 2023 and held it in 8 quarters. The position peaked at $585K in Q3 2024. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • American Century Companies reported no remaining Pyxis Oncology position as of Q1 2026 after selling out during the quarter.
  • American Century Companies sold 31,936 Pyxis Oncology shares in Q1 2026, an estimated $36.7K.
  • American Century Companies first reported a position in Pyxis Oncology in Q3 2023 and held it in 8 quarters.
  • American Century Companies's Pyxis Oncology position peaked at $585K in Q3 2024.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.